{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ward C"],"funding":["NIDDK NIH HHS","NIAID NIH HHS","Novo Nordisk Fonden"],"pagination":["1647-1655"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9271126"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["106(8)"],"pubmed_abstract":["<h4>Background</h4>The long-term outcomes of both pancreas and islet allotransplantation have been compromised by difficulties in the detection of early graft dysfunction at a time when a clinical intervention can prevent further deterioration and preserve allograft function. The lack of standardized strategies for monitoring pancreas and islet allograft function prompted an international survey established by an International Pancreas and Islet Transplant Association/European Pancreas and Islet Transplant Association working group.<h4>Methods</h4>A global survey was administered to 24 pancreas and 18 islet programs using Redcap. The survey addressed protocolized and for-cause immunologic and metabolic monitoring strategies following pancreas and islet allotransplantation. All invited prog"],"journal":["Transplantation"],"pubmed_title":["International Survey of Clinical Monitoring Practices in Pancreas and Islet Transplantation."],"pmcid":["PMC9271126"],"funding_grant_id":["R01 DK091331","NNF21OC0069731","T32 AI125222"],"pubmed_authors":["Uva PD","Stock PG","Thaunat O","International Pancreas and Islet Transplant Association Beta-Cell Replacement Therapy Monitoring Task Force","de Koning EJP","Odorico JS","Berney T","Stratta RJ","Cattral MS","Burke GW","Arbogast H","Kay TWH","Scholz H","Ward C","Rickels MR"],"additional_accession":[]},"is_claimable":false,"name":"International Survey of Clinical Monitoring Practices in Pancreas and Islet Transplantation.","description":"<h4>Background</h4>The long-term outcomes of both pancreas and islet allotransplantation have been compromised by difficulties in the detection of early graft dysfunction at a time when a clinical intervention can prevent further deterioration and preserve allograft function. The lack of standardized strategies for monitoring pancreas and islet allograft function prompted an international survey established by an International Pancreas and Islet Transplant Association/European Pancreas and Islet Transplant Association working group.<h4>Methods</h4>A global survey was administered to 24 pancreas and 18 islet programs using Redcap. The survey addressed protocolized and for-cause immunologic and metabolic monitoring strategies following pancreas and islet allotransplantation. All invited prog","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Aug","modification":"2025-04-04T20:07:15.946Z","creation":"2025-04-04T20:07:15.946Z"},"accession":"S-EPMC9271126","cross_references":{"pubmed":["35019897"],"doi":["10.1097/tp.0000000000004058","10.1097/TP.0000000000004058"]}}